ArticleInternational journal of clinical and experimental pathology2026
Prognostic value of fatty acid metabolism-related genes in colorectal cancer.
Article in International journal of clinical and experimental pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeColon cancer (CC), a malignancy with high global incidence and mortality, remains a major public health burden. As a pivotal aspect of tumor metabolic reprogramming, fatty acid metabolism has drawn significant research interest. This study was designed to elucidate the relationship between fatty acid metabolism-related gene expression and prognosis in patients with CC.
methodWe obtained the mRNA expression profiles and corresponding clinical information of colon cancers from The Cancer Genome Atlas (TCGA) database. Expression data of fatty acid metabolism-related genes and survival data were extracted for subsequent analysis. Univariate Cox regression and least absolute shrinkage and selection operator (LASSO) regression analyses were employed to identify fatty acid metabolism-related genes associated with prognosis in CC patients. Subsequently, a prognostic model based on these six genes was constructed to predict survival probability. Patients were stratified into high-risk and low-risk groups based on the model. Differences between the two groups were analyzed, including gene set enrichment analysis (GSEA), immune cell infiltration, immunotherapy efficacy, and immune checkpoint expression levels. Furthermore, a novel nomogram incorporating the risk score, age, gender, and clinical stage was developed to predict individual patient outcome. Finally, the expression levels of the identified risk genes were validated in cell lines using quantitative real-time PCR (qRT-PCR).
results449 CC and 41 normal samples were included in this study. A prognostic model based on six fatty acid metabolism-related genes (ENO3, ELOVL3, ACOT11, ALAD, ELOVL6, ACADL) were built to evaluate the prognosis of CC patients. Patients in the high-risk group had poorer overall survival than those in the low-risk group (
conclusionTargeting fatty acid metabolism-related genes represents a promising therapeutic strategy for colon cancer (CC) that could pave the way for personalized treatment and enhanced patient survival.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.